Artios Pharma, MD Anderson and ShangPharma announce in-licensing agreement for DNA damage response inhibitor
| Press release
Press release
Artios Pharma appoints Tania Dimitrova as Chief Business Officer and expands presence in the United States
| Press release
Artios Pharma Announces Appointment of Professor Rajesh Chopra as Non-Executive Director
| Press release
Artios exercises option to in-license potential first-in-class nuclease development programme
| Press release
